BIOE

Bio Essence Corp
—

Company Information

Company Name
Bio Essence Corp
CIK
CIK0001723059
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
BIOE: OTC
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
BIOE

SEC filing data through

Insider Sentiment

Last purchase
2023-06-06
Last sale
2024-10-30
Shares purchased (TTM)
0
Shares sold (TTM)
226,009
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
—
Institutional shares owned
—
Shares outstanding
—
Ownership
—

Earnings Market Reaction

Filing date
2026-08-14
Price on filing date
—
1-month reaction
-24.00%
3-month reaction
…
Drift continued3/8 (38%)
Faded / reversed5/8 (63%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Related Party0-----------
Cash And Cash Equivalents At Carrying Value---0--000000
Assets
Cash00----0-----
Accounts Receivable Net Current-00000000-00
Assets Of Disposal Group Including Discontinued Operation Current-------011--
Advances On Inventory Purchases00000000---0
Other Receivables Net Current-------0001-
Assets Current
Assets Current110000011100
Prepaid Expense Current----------00
Inventory Net----------00
Security Deposit--------0000
Deposits Assets Noncurrent----------0-
Prepaid Expense And Other Assets Current0000000-----
Deposits Assets Current-----000----
Interest Receivable Current0-----------
Operating Lease Right Of Use Asset--------111-
Property Plant And Equipment Net---------000
Assets Noncurrent
Assets Noncurrent30000-0---22
Intangible Assets Net Excluding Goodwill300000000000
Other Assets Noncurrent-----000-01-
Assets Of Disposal Group Including Discontinued Operation----------1-
Assets410000012232
Bank Overdrafts--0-00----00
Accounts Payable Current-00000000000
Deposit Liability Current011100000---
Accounts Payable And Other Accrued Liabilities Current000000000000
Finance Lease Liability Current----------00
Liabilities Current
Liabilities Current222333333322
Loans Payable Current-----------0
Interest Payable Current-----000000-
Taxes Payable Current00--------00
Operating Lease Liability Current222111111100
Liabilities And Stockholders Equity
Government Assistance Liability Current00000000000-
Operating Lease Liability Noncurrent----00011111
Finance Lease Liability Noncurrent----------00
Long Term Loans Payable-----------0
Liabilities Noncurrent
Government Assistance Liability Noncurrent00000000000-
Liabilities Noncurrent00000-0---11
Other Liabilities Noncurrent-----001-01-
Liabilities Of Disposal Group Including Discontinued Operation----------1-
Liabilities222334344444
Common Stock Value000000000000
Stockholders Equity
Additional Paid In Capital1187777777777
Stockholders Equity2-1-2-3-3-3-3-3-2-2-2-1
Retained Earnings Accumulated Deficit-9-9-10-11-11-11-10-10-9-9-9-9
Liabilities And Stockholders Equity410000012232
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized101010101010101010101010
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized100100100100100100100100100100100100
Common Stock Shares Issued544738383838383838383838
Shares Outstanding544738383838383838383838

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Bio Essence Corp (BIOE) — SEC Financial Statements & Analysis

Bio Essence Corp (BIOE) is a pharmaceutical preparations company, incorporated in CA. Bio Essence Corp trades on OTC as: BIOE. Bio Essence Corp (BIOE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Bio Essence Corp carries a market cap of $13.74M, a P/E ratio of 9.05x, a P/B ratio of 5.87x, a P/S ratio of 4.72x, an enterprise value of $13.74M, and an EV/EBITDA multiple of 8.36x. On profitability, it posts a gross margin of 69.68%, an operating margin of 52.86%, a net margin of 52.12%, a Return on Equity (ROE) of -392.93%, and a Return on Assets (ROA) of 73.74%. Per share, it reports EPS of $0.03, diluted EPS of $0.02, free cash flow per share of $0.02, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 955.60% year-over-year, net income growth of -210.53% year-over-year, and EPS growth of -182.56% year-over-year. On the balance sheet, it maintains a current ratio of 0.38x, a quick ratio of 0.30x, working capital of $-998.52K, a debt-to-equity ratio of 0.71x, a debt ratio of 0.41, an interest coverage ratio of 386.67x, free cash flow of $1.08M (TTM), and net debt of $-675. Figures sourced from SEC EDGAR.

Market Cap
$13.74M
P/E TTM
9.05x
EPS TTM
$0.03
P/B TTM
5.87x
ROE TTM
-392.93%
ROA TTM
73.74%
Debt To Equity
0.71x
Free Cash Flow TTM
$1.08M
Net Revenue TTM Growth 1Y
955.60%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Bio Essence Corp in?

Bio Essence Corp (BIOE) operates in the Pharmaceutical Preparations industry.

What exchange does BIOE trade on?

Bio Essence Corp (BIOE) trades on the OTC.

Where is Bio Essence Corp incorporated?

Bio Essence Corp is incorporated in CA.

When was Bio Essence Corp (BIOE)'s most recent SEC filing?

Bio Essence Corp (BIOE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.

What is BIOE's market cap?

Bio Essence Corp (BIOE) has a market capitalization of $13.74M as of 2026-06-30.

What is BIOE's P/E ratio?

Bio Essence Corp (BIOE)'s trailing twelve month P/E ratio is 9.05x as of 2026-06-30.

What is BIOE's EPS (earnings per share)?

Bio Essence Corp (BIOE)'s trailing twelve month EPS is $0.03 as of 2026-06-30.

What is BIOE's ROE (return on equity)?

Bio Essence Corp (BIOE)'s trailing twelve month Return on Equity (ROE) is -392.93% as of 2026-06-30.

What is BIOE's ROA (return on assets)?

Bio Essence Corp (BIOE)'s trailing twelve month Return on Assets (ROA) is 73.74% as of 2026-06-30.

What is BIOE's EV/EBITDA?

Bio Essence Corp (BIOE)'s trailing twelve month EV/EBITDA is 8.36x as of 2026-06-30.

Wall Street's data.
Main Street's price.